Researchers are harnessing the power of array and NGS technologies to conduct large-scale, global genetic analyses of complex diseases. This high-throughput genomic research is focused on multifactorial genetic discovery of markers related to disease risk. These studies look for changes in structural variation, single nucleotide polymorphisms (SNPs), indels, splice variants, methylation markers.
High-throughput genomic studies with tens to hundreds of thousands of samples require fast, cost-effective array and sequencing tools. Illumina offers array and NGS technologies with unprecedented sample-to-analysis solutions and unparalleled collaborative expertise to meet these needs.
Researchers perform genome-wide association studies to identify disease-associated DNA risk loci and develop scores for clinical validation.Read Interview
Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of project.Learn More
For labs preparing large quantities of NGS libraries, liquid-handling robots and other automation solutions provide a good option.Learn More
Illumina Advantage large-scale sequencing products offer the highest level of service and support to ensure operational success for clinical research laboratories.Learn More
National population genomics programs seek to integrate large, diverse data sets, combining clinical information with genomic data at scale in a learning health system.Learn More
Find arrays that make cost-effective, large-scale genotyping studies possible.Learn More
There are many genetic loci involved in cancer risk. Read more about how using NGS to understand the polygenicity of cancer can help researchers predict cancer risk and customize precision prevention.Read Article